Navigation Links
Onyx Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/4/2011

)Net loss per share:Basic$
(0.78)$
(0.19)Diluted (4)$
(0.78)$
(0.19)Computation of diluted shares:Basic 63,00862,353Dilutive effect of options--Diluted (4)63,00862,353(1)  Includes employee stock-based compensation charges of:Research and development$
926$
912Selling, general, and administrative4,4294,030Total employee stock-based compensation$
5,355$
4,942(2)
Includes a $12.7 million non-cash expense related to the unamortized balance of funding provided to S*BIO in May 2010.

(3) Includes a $3.0 million impairment charge which reflects the reassessment of the fair value of Onyx's equity investment in S*BIO.

(4) Under the "if-converted" method, interest and issuance costs and potential common shares related to the Company's convertible senior notes were excluded in the computation of diluted per share amounts for the three months ended March 31, 2011 and 2010 because their effect would be anti-dilutive. ONYX PHARMACEUTICALS, INC.CALCULATION OF REVENUE FROM COLLABORATION AGREEMENT(In thousands, unaudited)Three Months EndedMarch 31, 20112010Nexavar product revenue, net (as recorded by Bayer)$ 235,467$ 214,361Nexavar revenue subject to profit sharing (as recorded by Bayer)$ 193,170$ 185,867Combined cost of goods sold, distribution, selling, general and administrative expenses74,01075,698Combined collaboration commercial profit$ 119,160$ 110,169Onyx's share of collaboration commercial profit$   59,580$   55,084Reimbursement of Onyx's shared marketing expenses4,6045,824Royalty revenue2,9611,995Revenue from collaboration agreement$   67,145$   62,903ONYX PHARMACEUTICALS, INC.RECONCILIATION OF GAAP TO NON-GAAP NET LOSS(In thousands, except per share amounts)(unaudited)Three Months EndedMarch 31, 20112010GAAP net loss$(49,162)$(12,044)Non-GAAP adjustments:Contingent consideration11,4953,448Employee stock-based compensation5,3554,942Imputed interest related to the conver
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2014. Cash and investments in ... compared to $309.1 million at March 31, 2014."The second half ... we look forward to significant milestones for a number of ... Chief Executive Officer of Nektar. "The first of these is ...
(Date:7/31/2014)...  UBM Medica US announces that Cancer ... presents exclusive slide shows dealing with communication in the ... care. Cancer Network, the online ... blogs, and podcasts about the latest clinical findings. Among ... , End-of-life care is challenging for even the ...
(Date:7/31/2014)... , July 31, 2014  Decision Resources Group ... market intelligence product Marketrack to now include ChinaTrack; the ... device landscape in an interactive dashboard providing detailed brand-level ... volumes at a hospital level. Other key ... Updated data feed: In addition to end-user surveys of ...
Breaking Medicine Technology:Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
... Feb. 8, 2011 Pharmaceutical Care Management Association (PCMA) ... today on Florida Governor Rick Scott,s Medicaid savings proposal: ... reduce wasteful spending in Medicaid, which is a big ... its old-school ,fee-for-service, approach, Florida Medicaid pays drugstores much ...
... (Nasdaq: DYNT ) plans to release financial results ... during the morning of Monday, February 14, 2011.   ... that day at 1:30 p.m. ET to discuss its results ... 926-7431 and use access code: 5687000. Dynatronics manufactures, ...
Cached Medicine Technology:
(Date:8/1/2014)... 1, 2014Lesbian, gay, bisexual, and transgender individuals who want ... as some of their heterosexual and cisgendered peers, such ... additional physiological and legal challenges to become parents. ... assisted reproduction options is presented in the article " ... published in LGBT Health , a ...
(Date:8/1/2014)... London, UK (PRWEB) August 01, 2014 ... Scientific Publications research reports have been added to ... 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research ... . The key pharma industry drivers include, among ... awareness of personal hygiene. In 2015, the pharma ...
(Date:8/1/2014)... -- Patients with the progressive, deadly respiratory ailment known ... weapon to battle the disease, the U.S. Food and ... a new treatment, an inhaled spray called Striverdi Respimat ... COPD, which is often linked to smoking, involves multiple ... Patients with COPD may experience a number of ...
(Date:8/1/2014)... The North America Endpoint Security Market report defines ... America with analysis and forecast of revenue. This market ... 2014 to $4.77 billion by 2019, at a CAGR ... the TOC of the North America Endpoint Security Market ... provided. It also provides a glimpse of the segmentation ...
(Date:8/1/2014)... 2014 (BRONX, NY) Scientists at Albert ... found that bacteria that aid in digestion help keep ... the journal Immunity , could yield new therapies ... of other disorders. , The research involved the intestinal ... of these microorganisms in promoting or preventing disease is ...
Breaking Medicine News(10 mins):Health News:Advances in assisted reproduction create more options and new legal issues for LGBT couples 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:FDA Approves New Treatment for People With COPD 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:'Normal' bacteria vital for keeping intestinal lining intact 2
... border with hard-hit China. ,The first confirmed case of SARS ... river, which forms the frontier with China, came as Chinese ... could contain the disease.,Hu told students in Moscow, at the ... measures to stop the spread of the deadly virus and ...
... key step towards ensuring rapid action against future ... international public health. A resolution adopted today confirms ... to verify disease outbreaks from all available official ... the severity of an outbreak through on-the-spot investigations ...
... Alzheimer's affects about 12 million people worldwide. Lithium may ... an enzyme called GSK-3 that facilitates the modification of ... GSK-3 as a target could help in developing other ... ,Another advantage to lithium is that it does not ...
... the smallest number of new cases since the Beijing ... the SARS epidemic last month. Two additional deaths also ... China's death toll from Severe Acute Respiratory Syndrome to ... at 5,316. ,Hong Kong reported just one new ...
... Health Organization has lifted its SARS-related travel warnings for ... breakthrough in the origin of the virus emerged. It ... praised national health authorities for controlling the outbreak in ... the lifting of the warning, praising the efforts of ...
... said that mammograms remain the most ,important tool in ... 40 years of age ,receive mammograms ,annually. Researchers say ... ,of cancers. They also said ,that self-examination did not ... that have grown for two years, while self-exams detect ...
Cached Medicine News:Health News:Lithium May help in Alzheimer's Disease 2
The Hilan pneumatic high speed drill system consists of a pneumatic motor and drill with various cutting attachments....
The XK-95 High Speed Drill System sets new technological and performance standards for surgical drill systems....
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region. The system has been approved in over 120 cases....
... The Ruggles Retractor System, a ... and the versatility of two systems ... hands from the surgical site during ... accurate retractor insertion. The retractor body ...
Medicine Products: